Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/1535-7163.MCT-08-0148PMID 18790747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.

  2008cited by this paper
• Evidence for Two Modes of Development of Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance

  2007cited by this paper
• The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells

  2007cited by this paper
• HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells

  2007cited by this paper
• Cellular FLICE-inhibitory protein regulates chemotherapy-induced apoptosis in breast cancer cells

  2007cited by this paper
• Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.

  2007cited by this paper
• Interleukin-8 Signaling Promotes Translational Regulation of Cyclin D in Androgen-Independent Prostate Cancer Cells

  2007cited by this paper
• MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).

  2007cited by this paper
• Targeting death-inducing receptors in cancer therapy

  2007cited by this paper
• Targeting the short form of cFLIP by RNA interference is sufficient to enhance TRAIL sensitivity in PC3 prostate carcinoma cells

  2006cited by this paper
• Sensitization of TRAIL–resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin

  2006cited by this paper
• c-FLIP inhibits chemotherapy-induced colorectal cancer cell death

  2006influential reference
• APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy.

  2006cited by this paper
• Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.

  2006cited by this paper
• The role of cellular flice inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer

  2006cited by this paper
• Activated nuclear factor-kappa B and cytokine profiles in the esophagus parallel tumor regression following neoadjuvant chemoradiotherapy.

  2005cited by this paper
• Selective Knockdown of the Long Variant of Cellular FLICE Inhibitory Protein Augments Death Receptor-mediated Caspase-8 Activation and Apoptosis*

  2005cited by this paper
• TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway

  2005cited by this paper
• The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim

  2005cited by this paper
• Expression of interleukin‐8 gene in radical prostatectomy specimens is associated with advanced pathologic stage

  2005cited by this paper
• Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells.

  2005cited by this paper
• Nonapical and Cytoplasmic Expression of Interleukin-8, CXCR1, and CXCR2 Correlates with Cell Proliferation and Microvessel Density in Prostate Cancer

  2005influential reference
• The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells.

  2005influential reference
• Predictive value of serum interleukin‐8 levels in ovarian cancer patients treated with paclitaxel‐containing regimens

  2005cited by this paper
• Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms

  2004cited by this paper
• Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-KB through suppression of IKBA phosphorylation

  2004cited by this paper
• Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK

  2004cited by this paper
• Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation.

  2004cited by this paper
• Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

  2004cited by this paper
• Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

  2004cited by this paper
• Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.

  2004cited by this paper
• X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells.

  2004cited by this paper
• Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death.

  2004cited by this paper
• Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expression.

  2004cited by this paper
• Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.

  2003cited by this paper
• Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3.

  2003cited by this paper
• Influence of cytokine gene polymorphisms on the development of prostate cancer.

  2002cited by this paper
• Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Induces Caspase-Dependent Interleukin-8 Expression and Apoptosis in Human Astroglioma Cells

  2002cited by this paper
• Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice.

  2001cited by this paper
• Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.

  2000cited by this paper
• Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

  2000cited by this paper
• Cytokines IL-1b, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFa in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

  1999cited by this paper
• Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer.

  1999cited by this paper
• CXC‐chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor

  1999cited by this paper
• Inhibition of death receptor signals by cellular FLIP

  1997cited by this paper

• Genes Encoding Multiple Modulators of the Immune Response Are Methylated in the Prostate Tumor Microenvironment of African Americans

  2025cites this paper
• Third-trimester trophoblast stem cell function is impaired in fetal growth restriction.

  2025cites this paper
• Interactions and communications in the prostate tumour microenvironment: evolving towards effective cancer therapy

  2024cites this paper
• IL-8 and PI3K pathway influence the susceptibility of TRAIL-sensitive colorectal cancer cells to TRAIL-induced cell death

  2024cites this paper
• Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells

  2024cites this paper
• Advances in landscape and related therapeutic targets of the prostate tumor microenvironment

  2023cites this paper
• Combined serum CXCL8, CXCL9 and CXCL13 tests for the prediction of microvascular invasion in hepatocellular carcinoma.

  2023cites this paper
• Systematic Review of Comparative Transcriptomic Studies of Cellular Resistance to Genotoxic Stress.

  2023cites this paper
• CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth

  2023cites this paper
• Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer.

  2023cites this paper
• Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy

  2022cites this paper
• The Challenges and Emerging Opportunities of Targeting Cytokines and Chemokine-Driven Inflammatory Signals in Metastatic Castrate-Resistant Prostate Cancer.

  2022cites this paper
• The Roles of Tumor-Associated Macrophages in Prostate Cancer

  2022cites this paper
• An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer

  2021cites this paper
• Combinatorial therapy in tumor microenvironment: Where do we stand?

  2021cites this paper
• In Silico Modeling of the Induction of Apoptosis by Cryptotanshinone in Osteosarcoma Cell Lines

  2020cites this paper
• Erratum to MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8

  2020cites this paper
• Hsp60 and IL-8 axis promotes apoptosis resistance in cancer

  2019cites this paper
• RETRACTED ARTICLE: Significance of the IL-8 pathway for immunotherapy

  2019cites this paper
• The evaluation of urine concentration and diagnostic usefulness of interleukin-8 and interleukin-18 in bladder cancer diagnostics – preliminary report

  2019cites this paper
• Modified Ginseng Extract Induces Apoptosis in HepG2 Cancer Cells by Blocking the CXCL8-Mediated Akt/Nuclear Factor-[Formula: see text]B Signaling Pathway.

  2018cites this paper
• Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site

  2018cites this paper
• Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells

  2018cites this paper
• ShRNA-mediated knock-down of CXCL8 inhibits tumor growth in colorectal liver metastasis.

  2018cites this paper
• Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases

  2017cites this paper
• Targeting cFLIP to inhibit residual cancer stem cells after chemotherapy

  2017cites this paper
• Low vitamin D status is associated with inflammation in patients with prostate cancer

  2017cites this paper
• Role of the CXCL 8-CXCR 1 / 2 Axis in Cancer and Inflammatory Diseases

  2017cites this paper
• Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology

  2017cites this paper
• Suppression of c‑FLIPL promotes JNK activation in malignant melanoma cells.

  2016cites this paper
• JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells

  2016cites this paper
• The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity

  2016cites this paper
• Cabazitaxel for the Treatment of Prostate Cancer

  2016cites this paper
• The CXCL8-CXCR1/2 pathways in cancer

  2016cites this paper
• Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses.

  2016cites this paper
• Collagen binding integrins and cancer testis antigens in prostate cancer and melanoma

  2016cites this paper
• TXNIP mediates the differential responses of A549 cells to sodium butyrate and sodium 4‐phenylbutyrate treatment

  2016cites this paper
• Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage

  2015cites this paper
• Brief Report: Autocrine Cytokine–Mediated Deficiency of TRAIL‐Induced Monocyte Apoptosis in Rheumatoid Arthritis

  2015cites this paper
• Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness

  2015cites this paper
• Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)

  2015cites this paper
• The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma

  2015cites this paper
• The Nuclear Factor κB pathway: A link to the immune system in the radiation response.

  2015cites this paper
• Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells

  2014cites this paper
• Mesenchymal Stem Cell-Induced Doxorubicin Resistance in Triple Negative Breast Cancer

  2014cites this paper
• Redox-Mediated and Ionizing-Radiation-Induced Inflammatory Mediators in Prostate Cancer Development and Treatment

  2014cites this paper
• Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.

  2014cites this paper
• Maintaining and reprogramming genomic androgen receptor activity in prostate cancer

  2014cites this paper
• miR-200c Regulates IL8 Expression by Targeting IKBKB: A Potential Mediator of Inflammation in Leiomyoma Pathogenesis

  2014cites this paper
• Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer

  2014cites this paper
• Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients.

  2014cites this paper
• IL‐32γ enhances TNF‐α‐induced cell death in colon cancer

  2014cites this paper
• Detection of CXCR2 cytokine receptor surface expression using immunofluorescence.

  2014cites this paper
• Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other viruses.

  2014cites this paper
• FLIP: Molecular switch between apoptosis and necroptosis

  2014cites this paper
• ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity.

  2014cites this paper
• Interleukin 22 protects colorectal cancer cells from chemotherapy by activating the STAT3 pathway and inducing autocrine expression of interleukin 8.

  2014cites this paper
• The Rest of Interleukins

  2014cites this paper
• The Role Of IL-8-Mediated Src Family Kinase Activation In Tumor-Tumor And Tumor-Stromal Interactions In Metastasis Of Prostate Cancer

  2013cites this paper
• Targeting c-FLIP in cancer.

  2013cites this paper
• Phylogeographic Origin of Helicobacter pylori Determines Host-Adaptive Responses upon Coculture with Gastric Epithelial Cells

  2013cites this paper
• Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.

  2013cites this paper
• Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer

  2013cites this paper
• Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

  2013cites this paper
• Use of in vitro primary culture models to investigate the activity of standard and novel therapies in haematological malignancies

  2013cites this paper
• Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells

  2013cites this paper
• Helicobacter pylori and interleukin-8 in gastric cancer.

  2013cites this paper
• REDOX-REGULATED RELB-AR AXIS MEDIATES PROSTATE SPECIFIC ANTIGEN EXPRESSION: INSIGHT IN PROSTATE CANCER RESPONSE TO RADIATION THERAPY

  2013cites this paper
• Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives

  2012cites this paper
• G 31 P , an Antagonist against CXC Chemokine Receptors 1 and 2 , Inhibits Growth of Human Prostate Cancer Cells in Nude Mice

  2012cites this paper
• ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein

  2012cites this paper
• Herpesviruses and Cancer

  2012cites this paper
• G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.

  2012cites this paper
• Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL

  2012influential citation
• Constitutive and Treatment-Induced CXCL8-Signalling Selectively Modulates the Efficacy of Anti-Metabolite Therapeutics in Metastatic Prostate Cancer

  2012cites this paper
• Melanoma-Associated Cancer-Testis Antigen 16 (CT16) Regulates the Expression of Apoptotic and Antiapoptotic Genes and Promotes Cell Survival

  2012cites this paper
• Resistance to TRAIL and how to surmount it

  2012cites this paper
• Clusterin and Chemotherapy Sensitivity Under Normoxic and Graded Hypoxic Conditions in Colorectal Cancer

  2012cites this paper
• Evaluation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy in antagonizes therapeutic

  2012influential citation
• Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models

  2011cites this paper
• PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ.

  2011cites this paper
• Cytokine disbalance in common human cancers.

  2011cites this paper
• Multiple roles of interleukin-6 in prostate cancer

  2011cites this paper
• Absence of Mucosal Inflammation in Uncomplicated Diverticular Disease

  2011cites this paper
• Activating transcription factor‐2 in survival mechanisms in head and neck carcinoma cells

  2011cites this paper
• Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis.

  2010cites this paper
• In vitro and in vivo characterisation of a novel c-FLIP-targeted antisense phosphorothioate oligonucleotide

  2010cites this paper
• Immunotherapeutics in development for prostate cancer.

  2009cites this paper
• Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.

  2009cites this paper
• Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells

  2009cites this paper
• RNA interference in cancer: targeting the anti-apoptotic protein c-FLIP for drug discovery.

  2009cites this paper
• The good and the bad of chemokines/chemokine receptors in melanoma

  2009cites this paper
• Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer

  2008influential citation
• Cell Morphological Change and Caspase-3 Protein Expression on Epithelial Cells under Stimulation of Oral Bacterium Streptococcus sanguinis

  2008cites this paper
• Microsoft Word-9318154-file00

  2008cites this paper
• Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor-κB Transcription and Evasion of Apoptosis

  2008cites this paper
• The Interleukin-8 Pathway in Cancer

  2008cites this paper